healthy adults
Conditions
Interventions
4 weeks Administration of EPA (epadel, 1800mg/day) for healthy adults
Sponsors
Department of Psychiatry,Institute of Health Biosciences,The University of Tokushima Graduate School
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects are medical personnel belonging to the department of psychiatry,Tokushima university hospital or related organizations.
Exclusion criteria
Exclusion criteria: Persons on medications are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The change of genes expression in peripheral leukocyte of healthy adults before and after EPA administration. | — |
Countries
Japan
Outcome results
None listed